Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anteris Technologies Global Corp.AVR · Entity 5089 | Director | June 07, 2026 | June 10, 2026 |
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director · President and Director | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anteris Technologies Global Corp.
Report date June 07, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,580 |
Reported balance
After 2026-06-07 transaction · row 1
1 source rowRow 1 · 2026-06-07 · Exercise / conversion · Acquired 17,580 · Balance 17,580 F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 35,162 |
Reported balance
After 2026-06-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-07 · Exercise / conversion · Disposed 17,580 · Balance 35,162 F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis. F2: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis.
F2: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 25.4682 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 25.4682 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 24.7852 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 24.7852 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 30.34 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 3.6322 · Balance 30.34 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 32.3815 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 4.3524 · Balance 32.3815 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 17.5403 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 3.1566 · Balance 17.5403 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 18.6239 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 3.5757 · Balance 18.6239 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 1.9861 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 0.3056 · Balance 1.9861 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 2.0893 |
Reported balance
After 2026-09-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-09-03 · Grant · Acquired 0.3453 · Balance 2.0893 F8: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.6627 |
Reported balance
After 2026-09-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-09-03 · Grant · Acquired 5.2874 · Balance 13.6627 F9: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F8: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F9: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 27, 2025 Filed Mar 31, 2025 21:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.1816 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010269 · rdgdoc.xml · derivative · entry 7 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.1816 Underlying: Common Stock · 3.1816 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.9389 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010269 · rdgdoc.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17.8502 Underlying: Common Stock · 4.9389 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.1217 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010269 · rdgdoc.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18.033 Underlying: Common Stock · 4.1217 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.2147 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010269 · rdgdoc.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27.993 Underlying: Common Stock · 3.2147 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.2147 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010269 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28.676 Underlying: Common Stock · 3.2147 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.5788 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010269 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22.3696 Underlying: Common Stock · 1.5788 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 21:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.8293 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010269 · rdgdoc.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15.6142 Underlying: Common Stock · 0.8293 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 20:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,818 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-25-007044 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123 Underlying: Common Stock · 2,818 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 20:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,818 | $35.48 | $99,982.64 |
DisclosureSEC source: 0001437749-25-007044 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,976 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006155 · rdgdoc.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12.9113 Underlying: Common Stock · 5 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 203 | $91.85 | $18,645.55 |
DisclosureSEC source: 0001437749-25-006155 · rdgdoc.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,158 F4 · shares: These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 8, 2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006155 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 685 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006155 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,356 F1 · shares: These shares represent LMAT common stock acquired on February 28, 2025, upon settlement of a Performance Share Unit (PSU) award granted on December 8, 2023. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years. F2 · price: Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 741 | $0.00 Strike: $100.74 | $0.00 |
DisclosureSEC source: 0001437749-25-004598 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 741 Underlying: Common Stock · 741 shares Expires 2032-02-18 F2 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on December 6, 2025, 2026, 2027 and 2028. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 129 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-004598 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,671 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on December 6, 2025, 2026, 2027 and 2028. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 21:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-038388 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.0733 Underlying: Common Stock · 17 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 21:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 115 | $92.12 | $10,593.80 |
DisclosureSEC source: 0001437749-24-038388 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,542 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 21:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-038388 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 23:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037503 · rdgdoc.xml · derivative · entry 9 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24.7783 Underlying: Common Stock · 11 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 23:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037503 · rdgdoc.xml · derivative · entry 8 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25.4613 Underlying: Common Stock · 11 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 23:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 197 | $100.28 | $19,755.16 |
DisclosureSEC source: 0001437749-24-037503 · rdgdoc.xml · nonDerivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,640 F4 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock unites (PSU) awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 23:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 197 | $100.28 | $19,755.16 |
DisclosureSEC source: 0001437749-24-037503 · rdgdoc.xml · nonDerivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,837 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 23:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037503 · rdgdoc.xml · nonDerivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 23:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037503 · rdgdoc.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 23:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037503 · rdgdoc.xml · derivative · entry 7 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20.7908 Underlying: Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 23:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 196 | $101.00 | $19,796.00 |
DisclosureSEC source: 0001437749-24-037503 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,012 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 11, 2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 23:00 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037503 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 02:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037269 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.9113 Underlying: Common Stock · 4 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 02:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 169 | $101.12 | $17,089.28 |
DisclosureSEC source: 0001437749-24-037269 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,190 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 8, 2023. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 09, 2024 Filed Dec 12, 2024 02:08 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037269 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 22:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 7,662 | $0.00 Strike: $101.12 | $0.00 |
DisclosureSEC source: 0001437749-24-037123 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,662 Underlying: Common Stock · 7,662 shares Expires 2031-12-06 F2 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 22:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 1,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037123 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,355 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:52 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.5929 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037033 · rdgdoc.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17.9113 Underlying: Common Stock · 3.5929 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:52 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.1531 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037033 · rdgdoc.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35.7783 Underlying: Common Stock · 3.1531 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:52 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.1531 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037033 · rdgdoc.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36.4613 Underlying: Common Stock · 3.1531 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:52 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.0636 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037033 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38.7908 Underlying: Common Stock · 2.0636 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:52 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.5426 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037033 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.7849 Underlying: Common Stock · 0.5426 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 23:52 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.576 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-037033 · rdgdoc.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19.0733 Underlying: Common Stock · 0.576 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-036707 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.2423 Underlying: Common Stock · 12 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 106 | $105.47 | $11,179.82 |
DisclosureSEC source: 0001437749-24-036707 · rdgdoc.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,020 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 2, 2020. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-036707 · rdgdoc.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.1477 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028306 · rdgdoc.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.3184 Underlying: Common Stock · 4.1477 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.6399 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028306 · rdgdoc.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32.6252 Underlying: Common Stock · 3.6399 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.6399 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028306 · rdgdoc.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33.3082 Underlying: Common Stock · 3.6399 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.3821 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028306 · rdgdoc.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36.7272 Underlying: Common Stock · 2.3821 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.252 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028306 · rdgdoc.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26.2423 Underlying: Common Stock · 1.252 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.6646 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028306 · rdgdoc.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18.4973 Underlying: Common Stock · 0.6646 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 22:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,941 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-24-027053 · rdgdoc.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,941 Underlying: Common Stock · 2,941 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 22:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 122 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001437749-24-027053 · rdgdoc.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 122 shares Expires 2025-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 22:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 3,063 | $82.07 | $251,380.41 |
DisclosureSEC source: 0001437749-24-027053 · rdgdoc.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,114 F2 · shares: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $82.05 to $82.30. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.